$12.25
1.008.89%
Last update: Nov 6, 4:42 PM
4D Molecular Therapeutics Inc
FDMTNASDAQ
The average analyst price target for 4D Molecular Therapeutics is $32.18, 162.7% above the current price. Of 13 analysts, 12 rate it Buy and 1 Sell. Targets range from $6 to $58. The latest change came on Oct 6, 2026, when Chardan Capital lowered its price target on 4D Molecular Therapeutics from $26 to $25 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
